Hosted on MSN1mon
Creo Medical Group finalizes 51% subsidiary saleL ONDON - Creo Medical (TASE:PMCN) Group plc (AIM: CREO), a medical device company specializing in minimally invasive surgical endoscopy, has completed the sale of a 51% interest in its European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback